We are live on ! Find out more
MYOK

MyoKardia, Inc. Common Stock
MYOK

Delisted

MYOK was delisted on the 16th of November, 2020.

Back to rankings

35 hedge funds and large institutions have $137M invested in MyoKardia, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+35
Holders Change %
–
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
35
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$48.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$17.9M
3
CAM
Cormorant Asset Management
Massachusetts
+$9.21M
4
PHS
PFM Health Sciences
California
+$8.55M
5
DCM
Driehaus Capital Management
Illinois
+$7.13M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$76K +$64.9K +5,310 New
NFA
27
Nationwide Fund Advisors
Ohio
$49K +$40.5K +3,310 New
SO
28
STRS Ohio
Ohio
$29K +$24.5K +2,000 New
BA
29
BlackRock Advisors
Delaware
$28K +$23.2K +1,897 New
Citigroup
30
Citigroup
New York
$28K +$23.4K +1,910 New
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$16.4K +$13.7K +1,118 New
TRCT
32
Tower Research Capital (TRC)
New York
$4K +$3.21K +262 New
Morgan Stanley
33
Morgan Stanley
New York
$2K +$1.6K +131 New
Barclays
34
Barclays
United Kingdom
$2K +$1.65K +135 New
Bank of America
35
Bank of America
North Carolina
$2K +$1.85K +151 New
1
2

MYOK Hedge Fund Activity: Q4 2015 in Review

35 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q4 2015, worth a combined $137M.

Buyers outnumbered sellers: 35 funds opened new MYOK positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $48.1M.

  • 35 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q4 2015, up from 0 in Q3 2015.
  • Funds reported $137M of MyoKardia, Inc. Common Stock stock for Q4 2015.
  • 35 funds opened new MyoKardia, Inc. Common Stock positions in Q4 2015 and 0 closed out, a net change of +35 holders.
  • The largest MyoKardia, Inc. Common Stock buyer in Q4 2015 was Fidelity Investments, an estimated $48.1M added.

Based on aggregated 13F filings for Q4 2015.